A detailed history of Financial Architects, Inc transactions in Pfizer Inc stock. As of the latest transaction made, Financial Architects, Inc holds 22,048 shares of PFE stock, worth $589,122. This represents 0.12% of its overall portfolio holdings.

Number of Shares
22,048
Previous 23,850 7.56%
Holding current value
$589,122
Previous $973,000 16.96%
% of portfolio
0.12%
Previous 0.16%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 09, 2023

SELL
$36.12 - $41.79 $65,088 - $75,305
-1,802 Reduced 7.56%
22,048 $808,000
Q1 2023

May 12, 2023

SELL
$39.39 - $51.28 $222,592 - $289,783
-5,651 Reduced 19.16%
23,850 $973,000
Q4 2022

Feb 06, 2023

BUY
$41.75 - $54.5 $64,128 - $83,712
1,536 Added 5.49%
29,501 $1.51 Million
Q3 2022

Nov 14, 2022

BUY
$43.76 - $53.42 $1.22 Million - $1.49 Million
27,965 New
27,965 $1.22 Million
Q2 2022

Aug 11, 2022

SELL
$46.53 - $55.17 $1.18 Million - $1.39 Million
-25,256 Closed
0 $0
Q1 2022

May 05, 2022

SELL
$45.75 - $56.69 $8,052 - $9,977
-176 Reduced 0.69%
25,256 $1.31 Million
Q4 2021

Feb 14, 2022

BUY
$41.32 - $61.25 $6,487 - $9,616
157 Added 0.62%
25,432 $1.5 Million
Q3 2021

Nov 12, 2021

SELL
$39.25 - $50.42 $5,691 - $7,310
-145 Reduced 0.57%
25,275 $1.09 Million
Q2 2021

Aug 10, 2021

BUY
$35.91 - $40.68 $17,093 - $19,363
476 Added 1.91%
25,420 $995,000
Q1 2021

May 17, 2021

SELL
$33.49 - $37.77 $10,884 - $12,275
-325 Reduced 1.29%
24,944 $904,000
Q4 2020

Feb 17, 2021

BUY
$33.47 - $42.56 $36,348 - $46,220
1,086 Added 4.49%
25,269 $930,000
Q3 2020

Nov 09, 2020

SELL
$31.75 - $37.25 $14,922 - $17,507
-470 Reduced 1.91%
24,183 $888,000
Q2 2020

Aug 11, 2020

BUY
$30.12 - $36.54 $47,649 - $57,806
1,582 Added 6.86%
24,653 $806,000
Q1 2020

May 07, 2020

SELL
$27.03 - $38.62 $40,977 - $58,547
-1,516 Reduced 6.17%
23,071 $753,000
Q4 2019

Feb 14, 2020

SELL
$32.92 - $37.36 $45,363 - $51,482
-1,378 Reduced 5.31%
24,587 $963,000
Q3 2019

Nov 06, 2019

SELL
$32.49 - $42.13 $762,312 - $988,496
-23,463 Reduced 47.47%
25,965 $933,000
Q2 2019

Aug 14, 2019

SELL
$36.98 - $41.52 $493,461 - $554,042
-13,344 Reduced 21.26%
49,428 $2.14 Million
Q1 2019

May 13, 2019

BUY
$37.5 - $41.2 $2.33 Million - $2.55 Million
62,005 Added 8084.09%
62,772 $2.67 Million
Q1 2019

May 03, 2019

SELL
$37.5 - $41.2 $2.45 Million - $2.69 Million
-65,399 Reduced 98.84%
767 $33,000
Q4 2018

Feb 01, 2019

SELL
$38.47 - $43.86 $4,039 - $4,605
-105 Reduced 0.16%
66,166 $2.89 Million
Q3 2018

Oct 29, 2018

SELL
$34.47 - $41.81 $22,819 - $27,678
-662 Reduced 0.99%
66,271 $2.92 Million
Q2 2018

Aug 03, 2018

SELL
$32.98 - $35.16 $54,944 - $58,576
-1,666 Reduced 2.43%
66,933 $2.43 Million
Q1 2018

Apr 23, 2018

SELL
$31.91 - $37.02 $230,932 - $267,913
-7,237 Reduced 9.54%
68,599 $2.44 Million
Q4 2017

Feb 12, 2018

SELL
$33.26 - $35.29 $109,192 - $115,857
-3,283 Reduced 4.15%
75,836 $2.75 Million
Q3 2017

Nov 01, 2017

BUY
$31.0 - $34.15 $2.39 Million - $2.64 Million
77,165 Added 3949.08%
79,119 $2.83 Million
Q3 2017

Oct 23, 2017

BUY
$31.0 - $34.15 $60,574 - $66,729
1,954
1,954 $70,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $150B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Financial Architects, Inc Portfolio

Follow Financial Architects, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Financial Architects, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Financial Architects, Inc with notifications on news.